Effectiveness of a Mobile Medical Van in Providing Screening Services for STDs and HIV

Authors

  • Jon Liebman,

    1. Jon Liebman is a Nurse Practitioner with the Holyoke Health Center, Holyoke, Massachusetts. Frederick Altice is with the Yale AIDS Program, New Haven, Connecticut. At the time of this research, Mary Pat Lamberti was the Nurse Practitioner on the CHCV.
    Search for more papers by this author
  • Mary Pat Lamberti,

    1. Jon Liebman is a Nurse Practitioner with the Holyoke Health Center, Holyoke, Massachusetts. Frederick Altice is with the Yale AIDS Program, New Haven, Connecticut. At the time of this research, Mary Pat Lamberti was the Nurse Practitioner on the CHCV.
    Search for more papers by this author
  • Frederick Altice

    1. Jon Liebman is a Nurse Practitioner with the Holyoke Health Center, Holyoke, Massachusetts. Frederick Altice is with the Yale AIDS Program, New Haven, Connecticut. At the time of this research, Mary Pat Lamberti was the Nurse Practitioner on the CHCV.
    Search for more papers by this author

Jon Liebman, A.N.P., Holyoke Health Center, 230 Maple Street, Holyoke, MA 01040. E-mail: jonanne@crocker.com

Abstract

This retrospective study assesses the efficacy of a mobile medical van in screening high risk individuals and identifying new cases of HIV and other sexually transmitted diseases (STDs) in an urban setting from July 1996 through March 1997. High risk sex and drug use were common, while consistent condom use was rare. Relatively few patients were screened for STDs; positive cases represented only a small proportion of the STD cases identified in the study community. The mobile program, however, accounted for 11.5% of all HIV tests conducted at public test sites in the city. Mobile medical programs have the potential to improve STD and HIV control efforts by providing services to high risk individuals who may lack access to care elsewhere. Doing so, however, will require more active case finding techniques, including new, less invasive techniques to test asymptomatic individuals.

Ancillary